Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: A controlled study

Thorax

Volumn 51, Issue 10, 1996, Pages 993-999

  Burke, C M ^a   Sreenan, S ^a   Pathmakanthan, S ^a   Patterson, Jennifer ^b   Schmekel, Birgitta ^c,e   Poulter, L W ^d  

^a Stroke and Hypertension Unit   (Ireland)

^b Astra Clinical Research Unit   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Asthma; Immunopathology; Inhaled corticosteroids; Physiology

Indexed keywords

BUDESONIDE; CORTICOSTEROID; HLA DR ANTIGEN; PLACEBO;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MALE; PEAK EXPIRATORY FLOW; PHYSIOLOGY; PRIORITY JOURNAL; SPIROMETRY;

EID: 0029851664     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.10.993     Document Type: Article

References (36)

1. Poulter LW, Power C, Burke CM. The relationship between bronchial immunopathology and hyper-responsiveness in asthma. Eur Respir J 1990;3:792-9.
2. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
3. Jeffrey PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma. Am Rev Respir Dis 1989; 140:1745-53.
4. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Kosinophils and mast cells in bronchoalveoiar lavage in subjects with mild asthma. Am Rev Respir Dis 1988;137: 62-9.
5. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
6. Poulter LW, Power C, Hutter C, Sreenan S, Burke C. T cells and other mononuclear cells in asthma. In: Kummer, ed. Asthma immunopathology and immunotherapy. New-York, Vienna: Springer-Verlag, 1993.
7. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;i:520.
8. Burke CM, Power C, Norris A, Schmekel B, Condez A, Poulter LW. Lung function and immunological changes of inhaled corticosteroid therapy in asthma, Eur Respir J 1992;5:73-9.
9. Djukanovic R, Wilson J, Britten K, Wilson SJ, Walls AF, Roche WR, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992;145:669-74.
10. Adelroth E, Rosenhall L, Johansson SA, Linden M, Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 1990;142:97-9.
11. Jeffrey PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145:890-9.
12. Durham SR, Kay AB. Eosinophils, bronchial hyperactivity and late phase asthmatic reactions. Clin Allergy 1985;15: 411-8.
13. Clarkson K, Power CK, O'Connell F, Pathmakanthan S, Burke CM. A comparative evaluation of propofol and midazolam as sedative agents in fibreoptic bronchoscopy. Chest 1993;104:1029-31.
14. Poulter LW, Campbell DA, Munro C, Janossy G. Discrimination to macrophages and dendritic (ID) cells of man using monoclonal antibodies. Scand J Immunol 1986; 24:351-7.
15. Smith SH, Brown MH, Rowe D, Callord RE, Beverley PCL. Functional subsets of helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology 1986;58:63-70.
16. Janossy G, Prentice HG. T cell subpopulations, monoclonal antibodies and their therapeutic applications. Clin Haematol 1982;11:631-61.
17. Batori G, Bofill M, Petrdyi G, Bollan SR, Janossy G. Comparative analysis of monoclonal antibodies of workshop T series on suspensions and tissue sections. In: Bernard A, ed. Leucocyte typing. Paris: Springer-Verlag, 1984:469-75.
18. Hogg N, MacDonald S, Slusdrenko M, Beverley PCL. Monoclonal antibodies specific for human monocytes, granulocytes, and endothelium. Immunology 1984;53:753-67.
19. Poulter LW, Campbell DA, Munro CD, Buthcher RG. The quantification of HLA-DR expression on human cells using immunocytochemistry. J Immunol Methods 1987;98: 227.
20. Granger S, Janossy G, Francis G, Blacklock H, Poulter LW. Elimination of T lymphocytes from human bone marrow with monoclonal T antibodies and cytolytic complement. Br J Haematol 1982;50:367.
21. Tai PC, Spry CJF, Peterson C, Venge P, Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophils cationic protein. Nature 1984;309: 182-4.
22. Poulter LW, Norris A, Power C, Condez A, Barnes H, Schmekel B, et al. T cell dominated inflammatory reactions in the bronchioles of asymptomatic asthmatics are also present in the nasal mucosa. Postgrad Med J 1991;67: 747-53.
23. Power CK, Burke CM, Sreenan S, Hurson B, Poulter LW. T cell and macrophage subsets in the bronchial wall of clinically healthy subjects. Eur Respir J 1994;7:437-41.
24. Janossy G, Bofill M, Poulter LW. Two colour immunofluorescence: analysis of the lymphoid system with monoclonal antibodies. In: Polack J, van Noorden S, eds. Immunocytochemistry: practical applications in pathology and biology. 2nd edn. Bristol: J Wright PSG: 1986.
25. Townley RG, Reeb R, Fitzgibbons T, Adolpson RL. The effects of corticosteroids on the beta adrenergic receptors in bronchial smooth muscle. J Allergy 1970;45:118-21.
26. 2 agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomised, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992;90: 32-41.
27. Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982;37:423-9.
28. Ryan G, Latimer K, Juniper E, Roberts R, Tech M, Hargreave F. Effect of beclomethasone dipropionate on bronchial responsiveness to histamine in controlled non steroiddependent asthma. J Allergy Clin Immunol 1985;75:25-30.
29. McFadden ER Jr. Corticosteroids and cromolyn sodium as modulators of airway inflammation. Chest 1988;94:181-4.
30. Jenkins CR, Woolcock AJ. Effect of prednisolone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study. Thorax 1988;43:378-84.
31. Rossi GA, Crimi E, Lantero S, Gianiori P. Late phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. Am Rev Respir Dis 1991;144:379-83.
32. Gleich GJ, Flavahan NA, Fujusawa T, Vanhoutte PM. The eosinophil as a mediator of damage to respiratory epithelium. J Allergy Clin Immunol 1988;81:776-81.
33. Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D. Cytotoxic properties of eosinophil major basic protein. J Immunol 1979;123:295-7.
34. Robinson D, Hamid Q, Sun Ying, Bentley A, Assoufi B, Durham S, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin 4, interleukin 5 and interferon gamma cytokine gene expression. Am Rev Respir Dis 1993;148:401-6.
35. Wierenga A, Snoek M, De Groot C, Chretien L, Bos JO, Jansen HM, et al. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990;144:4651-6.
36. Corrigan CJ, Halzku A, Gemov-Engesueth V, Doi S, Kikuchi Y, Takatsu K, et al. CD4 T lymphocyte activation in asthma is accompanied by increased serum concentration of interleukin 5: effect of glucocorticoid therapy. Am Rev Respir Dis 1993;147:540-7.